Cargando…
Outcomes of refractory or relapsed Hodgkin lymphoma patients with post-autologous stem cell transplantation brentuximab vedotin maintenance: a French multicenter observational cohort study
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Fondazione Ferrata Storti
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244814/ https://www.ncbi.nlm.nih.gov/pubmed/34965701 http://dx.doi.org/10.3324/haematol.2021.279564 |
| _version_ | 1784738606578925568 |
|---|---|
| author | Marouf, Amira Cottereau, Anne Segolene Kanoun, Salim Deschamps, Paul Meignan, Michel Franchi, Patricia Sibon, David Antoine, Clara Gastinne, Thomas Borel, Cecile Hammoud, Mohammad Sicard, Guillaume Gille, Romane Cavalieri, Doriane Stamatoullas, Aspasia Filliatre-Clement, Lauriane Lazarovici, Julien Chauchet, Adrien Fornecker, Luc-Matthieu Amorin, Sandy Rocquet, Mathieu Raus, Nicole Burroni, Barbara Rubio, Marie Therese Bouscary, Didier Quittet, Philippe Casasnovas, Rene Olivier Brice, Pauline Ghesquieres, Herve Tamburini, Jérôme Deau, Benedicte |
| author_facet | Marouf, Amira Cottereau, Anne Segolene Kanoun, Salim Deschamps, Paul Meignan, Michel Franchi, Patricia Sibon, David Antoine, Clara Gastinne, Thomas Borel, Cecile Hammoud, Mohammad Sicard, Guillaume Gille, Romane Cavalieri, Doriane Stamatoullas, Aspasia Filliatre-Clement, Lauriane Lazarovici, Julien Chauchet, Adrien Fornecker, Luc-Matthieu Amorin, Sandy Rocquet, Mathieu Raus, Nicole Burroni, Barbara Rubio, Marie Therese Bouscary, Didier Quittet, Philippe Casasnovas, Rene Olivier Brice, Pauline Ghesquieres, Herve Tamburini, Jérôme Deau, Benedicte |
| author_sort | Marouf, Amira |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9244814 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Fondazione Ferrata Storti |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92448142022-07-07 Outcomes of refractory or relapsed Hodgkin lymphoma patients with post-autologous stem cell transplantation brentuximab vedotin maintenance: a French multicenter observational cohort study Marouf, Amira Cottereau, Anne Segolene Kanoun, Salim Deschamps, Paul Meignan, Michel Franchi, Patricia Sibon, David Antoine, Clara Gastinne, Thomas Borel, Cecile Hammoud, Mohammad Sicard, Guillaume Gille, Romane Cavalieri, Doriane Stamatoullas, Aspasia Filliatre-Clement, Lauriane Lazarovici, Julien Chauchet, Adrien Fornecker, Luc-Matthieu Amorin, Sandy Rocquet, Mathieu Raus, Nicole Burroni, Barbara Rubio, Marie Therese Bouscary, Didier Quittet, Philippe Casasnovas, Rene Olivier Brice, Pauline Ghesquieres, Herve Tamburini, Jérôme Deau, Benedicte Haematologica Letter to the Editor Fondazione Ferrata Storti 2021-12-30 /pmc/articles/PMC9244814/ /pubmed/34965701 http://dx.doi.org/10.3324/haematol.2021.279564 Text en Copyright© 2022 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
| spellingShingle | Letter to the Editor Marouf, Amira Cottereau, Anne Segolene Kanoun, Salim Deschamps, Paul Meignan, Michel Franchi, Patricia Sibon, David Antoine, Clara Gastinne, Thomas Borel, Cecile Hammoud, Mohammad Sicard, Guillaume Gille, Romane Cavalieri, Doriane Stamatoullas, Aspasia Filliatre-Clement, Lauriane Lazarovici, Julien Chauchet, Adrien Fornecker, Luc-Matthieu Amorin, Sandy Rocquet, Mathieu Raus, Nicole Burroni, Barbara Rubio, Marie Therese Bouscary, Didier Quittet, Philippe Casasnovas, Rene Olivier Brice, Pauline Ghesquieres, Herve Tamburini, Jérôme Deau, Benedicte Outcomes of refractory or relapsed Hodgkin lymphoma patients with post-autologous stem cell transplantation brentuximab vedotin maintenance: a French multicenter observational cohort study |
| title | Outcomes of refractory or relapsed Hodgkin lymphoma patients with post-autologous stem cell transplantation brentuximab vedotin maintenance: a French multicenter observational cohort study |
| title_full | Outcomes of refractory or relapsed Hodgkin lymphoma patients with post-autologous stem cell transplantation brentuximab vedotin maintenance: a French multicenter observational cohort study |
| title_fullStr | Outcomes of refractory or relapsed Hodgkin lymphoma patients with post-autologous stem cell transplantation brentuximab vedotin maintenance: a French multicenter observational cohort study |
| title_full_unstemmed | Outcomes of refractory or relapsed Hodgkin lymphoma patients with post-autologous stem cell transplantation brentuximab vedotin maintenance: a French multicenter observational cohort study |
| title_short | Outcomes of refractory or relapsed Hodgkin lymphoma patients with post-autologous stem cell transplantation brentuximab vedotin maintenance: a French multicenter observational cohort study |
| title_sort | outcomes of refractory or relapsed hodgkin lymphoma patients with post-autologous stem cell transplantation brentuximab vedotin maintenance: a french multicenter observational cohort study |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244814/ https://www.ncbi.nlm.nih.gov/pubmed/34965701 http://dx.doi.org/10.3324/haematol.2021.279564 |
| work_keys_str_mv | AT maroufamira outcomesofrefractoryorrelapsedhodgkinlymphomapatientswithpostautologousstemcelltransplantationbrentuximabvedotinmaintenanceafrenchmulticenterobservationalcohortstudy AT cottereauannesegolene outcomesofrefractoryorrelapsedhodgkinlymphomapatientswithpostautologousstemcelltransplantationbrentuximabvedotinmaintenanceafrenchmulticenterobservationalcohortstudy AT kanounsalim outcomesofrefractoryorrelapsedhodgkinlymphomapatientswithpostautologousstemcelltransplantationbrentuximabvedotinmaintenanceafrenchmulticenterobservationalcohortstudy AT deschampspaul outcomesofrefractoryorrelapsedhodgkinlymphomapatientswithpostautologousstemcelltransplantationbrentuximabvedotinmaintenanceafrenchmulticenterobservationalcohortstudy AT meignanmichel outcomesofrefractoryorrelapsedhodgkinlymphomapatientswithpostautologousstemcelltransplantationbrentuximabvedotinmaintenanceafrenchmulticenterobservationalcohortstudy AT franchipatricia outcomesofrefractoryorrelapsedhodgkinlymphomapatientswithpostautologousstemcelltransplantationbrentuximabvedotinmaintenanceafrenchmulticenterobservationalcohortstudy AT sibondavid outcomesofrefractoryorrelapsedhodgkinlymphomapatientswithpostautologousstemcelltransplantationbrentuximabvedotinmaintenanceafrenchmulticenterobservationalcohortstudy AT antoineclara outcomesofrefractoryorrelapsedhodgkinlymphomapatientswithpostautologousstemcelltransplantationbrentuximabvedotinmaintenanceafrenchmulticenterobservationalcohortstudy AT gastinnethomas outcomesofrefractoryorrelapsedhodgkinlymphomapatientswithpostautologousstemcelltransplantationbrentuximabvedotinmaintenanceafrenchmulticenterobservationalcohortstudy AT borelcecile outcomesofrefractoryorrelapsedhodgkinlymphomapatientswithpostautologousstemcelltransplantationbrentuximabvedotinmaintenanceafrenchmulticenterobservationalcohortstudy AT hammoudmohammad outcomesofrefractoryorrelapsedhodgkinlymphomapatientswithpostautologousstemcelltransplantationbrentuximabvedotinmaintenanceafrenchmulticenterobservationalcohortstudy AT sicardguillaume outcomesofrefractoryorrelapsedhodgkinlymphomapatientswithpostautologousstemcelltransplantationbrentuximabvedotinmaintenanceafrenchmulticenterobservationalcohortstudy AT gilleromane outcomesofrefractoryorrelapsedhodgkinlymphomapatientswithpostautologousstemcelltransplantationbrentuximabvedotinmaintenanceafrenchmulticenterobservationalcohortstudy AT cavalieridoriane outcomesofrefractoryorrelapsedhodgkinlymphomapatientswithpostautologousstemcelltransplantationbrentuximabvedotinmaintenanceafrenchmulticenterobservationalcohortstudy AT stamatoullasaspasia outcomesofrefractoryorrelapsedhodgkinlymphomapatientswithpostautologousstemcelltransplantationbrentuximabvedotinmaintenanceafrenchmulticenterobservationalcohortstudy AT filliatreclementlauriane outcomesofrefractoryorrelapsedhodgkinlymphomapatientswithpostautologousstemcelltransplantationbrentuximabvedotinmaintenanceafrenchmulticenterobservationalcohortstudy AT lazarovicijulien outcomesofrefractoryorrelapsedhodgkinlymphomapatientswithpostautologousstemcelltransplantationbrentuximabvedotinmaintenanceafrenchmulticenterobservationalcohortstudy AT chauchetadrien outcomesofrefractoryorrelapsedhodgkinlymphomapatientswithpostautologousstemcelltransplantationbrentuximabvedotinmaintenanceafrenchmulticenterobservationalcohortstudy AT forneckerlucmatthieu outcomesofrefractoryorrelapsedhodgkinlymphomapatientswithpostautologousstemcelltransplantationbrentuximabvedotinmaintenanceafrenchmulticenterobservationalcohortstudy AT amorinsandy outcomesofrefractoryorrelapsedhodgkinlymphomapatientswithpostautologousstemcelltransplantationbrentuximabvedotinmaintenanceafrenchmulticenterobservationalcohortstudy AT rocquetmathieu outcomesofrefractoryorrelapsedhodgkinlymphomapatientswithpostautologousstemcelltransplantationbrentuximabvedotinmaintenanceafrenchmulticenterobservationalcohortstudy AT rausnicole outcomesofrefractoryorrelapsedhodgkinlymphomapatientswithpostautologousstemcelltransplantationbrentuximabvedotinmaintenanceafrenchmulticenterobservationalcohortstudy AT burronibarbara outcomesofrefractoryorrelapsedhodgkinlymphomapatientswithpostautologousstemcelltransplantationbrentuximabvedotinmaintenanceafrenchmulticenterobservationalcohortstudy AT rubiomarietherese outcomesofrefractoryorrelapsedhodgkinlymphomapatientswithpostautologousstemcelltransplantationbrentuximabvedotinmaintenanceafrenchmulticenterobservationalcohortstudy AT bouscarydidier outcomesofrefractoryorrelapsedhodgkinlymphomapatientswithpostautologousstemcelltransplantationbrentuximabvedotinmaintenanceafrenchmulticenterobservationalcohortstudy AT quittetphilippe outcomesofrefractoryorrelapsedhodgkinlymphomapatientswithpostautologousstemcelltransplantationbrentuximabvedotinmaintenanceafrenchmulticenterobservationalcohortstudy AT casasnovasreneolivier outcomesofrefractoryorrelapsedhodgkinlymphomapatientswithpostautologousstemcelltransplantationbrentuximabvedotinmaintenanceafrenchmulticenterobservationalcohortstudy AT bricepauline outcomesofrefractoryorrelapsedhodgkinlymphomapatientswithpostautologousstemcelltransplantationbrentuximabvedotinmaintenanceafrenchmulticenterobservationalcohortstudy AT ghesquieresherve outcomesofrefractoryorrelapsedhodgkinlymphomapatientswithpostautologousstemcelltransplantationbrentuximabvedotinmaintenanceafrenchmulticenterobservationalcohortstudy AT tamburinijerome outcomesofrefractoryorrelapsedhodgkinlymphomapatientswithpostautologousstemcelltransplantationbrentuximabvedotinmaintenanceafrenchmulticenterobservationalcohortstudy AT deaubenedicte outcomesofrefractoryorrelapsedhodgkinlymphomapatientswithpostautologousstemcelltransplantationbrentuximabvedotinmaintenanceafrenchmulticenterobservationalcohortstudy |